Ophthalmology · Coral Gables, FL
NPI
1114195260
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1097 S Lejeune Rd
Coral Gables, FL, 33134
Phone (305) 422-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,652
125 services
Medicare patients, 2024
64
Average age 76
Drug cost, 2024
$1.8M
20,104 prescriptions
Company payments, 2025
$905
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joel D Aronowicz-Gallego was code 92014 (ophthalmological e&m), 19 times for 19 patients. In total Joel D Aronowicz-Gallego billed 125 services in 18 codes, and Medicare paid $7,652.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 19 | 19 | $94.84 | $1,802 |
| 92133 Computerized Ophthalmic Imaging | Office | 19 | 19 | $21.67 | $412 |
| 92083 Vision, Hearing, and Speech Services | Office | 17 | 14 | $25.25 | $429 |
| 99214 Office E&M - Established | Office | 14 | 13 | $98.03 | $1,372 |
By year: 2022 $2,299 for 43 services; 2023 $4,672 for 63 services; 2024 $7,652 for 125 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joel D Aronowicz-Gallego prescribed most often to Medicare patients was Latanoprost, with 4,850 prescriptions and refills. In total Joel D Aronowicz-Gallego wrote 20,104 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 4,850 | 6,628 | 1,426 | $24K |
| Brimonidine Tartrate Generic | 1,775 | 2,184 | 506 | $35K |
| Lumigan Bimatoprost | 1,637 | 2,004 | 466 | $532K |
| Prednisolone Acetate Generic | 1,488 | 1,589 | 1,070 | $36K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,080 | 1,798 | 397 | $9,842 |
| Timolol Maleate Generic | 914 | 1,144 | 245 | $12K |
| Moxifloxacin Moxifloxacin Hcl | 909 | 911 | 848 | $16K |
| Erythromycin Erythromycin Base | 825 | 827 | 440 | $5,063 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 806 | 929 | 228 | $40K |
| Cyclosporine Generic | 799 | 802 | 274 | $40K |
| Dorzolamide Hcl Generic | 608 | 919 | 218 | $7,678 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 531 | 565 | 171 | $197K |
| Bromfenac Sodium Generic | 509 | 555 | 473 | $23K |
| Combigan Brimonidine Tartrate/Timolol | 391 | 555 | 110 | $123K |
| Rhopressa Netarsudil Mesylate | 353 | 397 | 129 | $128K |
Brand drugs: 10,100 claims; generic drugs: 10,004 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel D Aronowicz-Gallego $905 ($905 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $267 |
| Mallinckrodt Hospital Products Inc. | 7 | $211 |
| Alcon Vision LLC ALC | 10 | $205 |
| Thea Pharma Inc. | 4 | $67.96 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $37.51 |
| Dompe US, Inc. | 1 | $33.75 |
| Harrow Eye, LLC | 1 | $30.46 |
| Amgen Inc. AMGN | 1 | $25.9 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $24.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.